Rochester, MN, United States of America

Wayne T Nicholson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Mayo Foundation for Medical Education and Research, Regents of the University of Minnesota. Active years: 2022.


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wayne T Nicholson: Innovator in Pharmaceutical Formulations

Introduction

Wayne T Nicholson is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of sedation and analgesia. His innovative work has led to the development of a unique admixture that combines ketamine and propofol.

Latest Patents

Wayne T Nicholson holds a patent for a pharmaceutical formulation comprising ketamine, propofol, and a lipid. This formulation provides methods for sedation, amnesia, analgesia, anxiolysis, and stable hemodynamics. His patent represents a significant advancement in medical practices, offering new solutions for patient care.

Career Highlights

Throughout his career, Wayne has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and the Regents of the University of Minnesota. His experience in these institutions has allowed him to collaborate with leading experts in the medical field.

Collaborations

Wayne has collaborated with notable colleagues, including Nathan J Smischney and Jayanth Panyam. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Wayne T Nicholson's contributions to pharmaceutical formulations highlight his innovative spirit and dedication to improving medical practices. His work continues to influence the field and offers promising solutions for patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…